Understanding delirium in adult and pediatric ICU patients in the Czech Republic
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
This study looks at how often delirium happens and how it's managed in adult and child patients in intensive care units in the Czech Republic to see if current methods are effective.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Sex | All |
| Sponsor | Masaryk University Academic / other |
| Locations | 1 site (Brno) |
| Trial ID | NCT05891873 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the incidence and management of delirium in adult and pediatric patients admitted to intensive care units in the Czech Republic. It will follow two cohorts: adults with acute strokes in neurocritical care and children aged 6-18 years in pediatric intensive care. The study will assess the effectiveness of current delirium screening and prevention strategies over a minimum follow-up period of six months. By identifying gaps in knowledge and implementation of delirium management recommendations, the study seeks to improve patient outcomes in critical care settings.
Who should consider this trial
Good fit: Ideal candidates include adults with acute ischemic or hemorrhagic strokes and children aged 6-18 years admitted to the ICU for at least 24 hours.
Not a fit: Patients with severe trauma and a short life expectancy, or those whose ICU stay is less than 24 hours, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and management of delirium, reducing its incidence and associated complications in ICU patients.
How similar studies have performed: While there is existing research on delirium management in ICU settings, this study's specific focus on the Czech population and its dual cohort approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Neurointensive/neurocritical group (N-ICU): patients with acute ischaemic or haemorrhagic stroke admitted to the Stroke Unit or ICU of the Department of Neurology, University Hospital Brno (NK-UHB). * Paediatric intensive/critical group (P-ICU): children aged 6-18 years, admitted to the Paediatric ICU - Department of Paediatric Anaesthesiology and Intensive Care (KDAR-UHB) with a stay of at least 24 hours (including postoperative care). Exclusion Criteria: * (N-ICU) severe trauma with short life expectancy (days) * duration of the ICU stay shorter than 24 hours
Where this trial is running
Brno
- Brno University Hospital — Brno, Czechia (Recruiting)
Study contacts
- Study coordinator: Josef Bednařík, prof. MD, CSc.
- Email: bednarik.josef@fnbrno.cz
- Phone: 532231481
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.